ZEPP Insider Files Form 144 to Sell 44,000 Class A Shares (~$411K)

Rhea-AI Filing Summary

Zepp Health Corporation Form 144 reports a proposed sale of 44,000 Class A ordinary shares (American depositary shares representing underlying Class A shares) with an aggregate market value of $411,070.00. The shares represent a small portion of the company's outstanding stock of 114,776,364 shares and are planned to be sold on the NYSE with an approximate sale date of 09/04/2025. The filer acquired the securities on 02/12/2018 through stock options that vested on that date. The filing states there were no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR Routine officer/insider sale notice for 44,000 shares valued at $411k; immaterial relative to total shares outstanding.

This Form 144 is a standard notification required when an insider or related person proposes to sell restricted or control securities under Rule 144. The position size disclosed, 44,000 shares representing a $411,070 market value against 114,776,364 shares outstanding, appears modest and unlikely to be market-moving. The shares were acquired via stock options that vested on 02/12/2018, which explains the unrestricted status for sale. No prior sales in the past three months are reported, and the filing includes the required attestation regarding material non-public information.

Corporate Governance Expert

TL;DR Compliance disclosure consistent with governance and insider trading rules; no red flags in the filing itself.

The document fulfills procedural obligations by identifying the class, acquisition date, nature of acquisition (stock options), broker, planned sale date, and aggregate value. The absence of reported sales in the prior three months and the attestation about lack of undisclosed material adverse information are standard. There is no indication here of atypical timing, extraordinary volume, or governance-related concerns based solely on the disclosed facts.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ZEPP Class A Ordinary Shares	The Core Group Suite C 20/F 4-4A Des Voeux Road Central Hong Kong K3 Central	44000	411070.00	114776364	09/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ZEPP Class A Ordinary Shares	02/12/2018	Stock Options	Zepp Health Corporation			0	02/12/2018	Stock Options Vesting

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ZEPP Form 144 report?

The filing reports a proposed sale of 44,000 Class A ordinary shares with an aggregate market value of $411,070, to be sold on the NYSE around 09/04/2025.

How were the shares acquired according to the filing?

The filer acquired the shares on 02/12/2018 through stock options that vested on that date.

Does the filing show any sales in the past three months for ZEPP?

The filing states "Nothing to Report" for securities sold during the past three months.

What is the number of ZEPP shares outstanding noted in the filing?

The filing shows 114,776,364 shares outstanding.

Who is the broker handling the proposed sale?

The broker listed is The Core Group with an address in Hong Kong as provided in the filing.